Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial ('BACKBEAT Trial”) by the end of Q3 2026 Orchestra BioMed and Medtronic plc. (NYSE: MDT, 'Medtronic”), the Company’s ...
Most Americans see China as one of the United States' biggest rivals or adversaries, but largely as an economic threat, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results